核子醫學市場：按類型、應用程式、最終用戶和地區分類

Nuclear Medicine Market, By Type, By Application, By End User, By Geography

出版日期: 2025年06月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

核醫市場規模預計在 2025 年達到 183.2 億美元，預計到 2032 年將達到 385.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 11.2%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	183.2億美元
效能數據	2020-2024	預測期	2025-2032
預測期內的複合年成長率（2025-2032）	11.20%	預計金額（2032年）	385.2億美元

近年來，受慢性病發病率上升、核醫學技術進步以及個人化醫療需求不斷成長的推動，全球核醫市場取得了顯著成長。核子醫學涉及使用放射性物質進行診斷和治療，從而能夠早期發現和治療各種疾病，包括癌症、心血管疾病和神經系統疾病。該市場涵蓋廣泛的產品和服務，包括放射性藥物、影像設備和軟體解決方案，以滿足全球醫療專業人員和患者的多樣化需求。隨著醫療保健產業的不斷發展和創新技術的採用，核醫市場未來將進一步擴張和發展。

市場動態

全球核子醫學市場受到幾個關鍵促進因素、市場限制因素和市場機會的影響。其中一個關鍵促進因素是癌症和心血管疾病等慢性疾病的發生率不斷上升，這些疾病需要先進的診斷和治療性介入。此外，由於老年人更容易患與老齡化相關的疾病，預計全球老年人口的成長將推動對核醫學程序的需求。包括混合成像模式的開發和新型放射性藥物的引入在內的技術進步也在透過提高核醫學程序的準確性和效率來推動市場成長。然而，市場面臨某些限制，例如核醫設備的高成本以及對放射性藥物的核准和使用的嚴格監管要求。缺乏接受過核子醫學技術培訓的熟練專業人員也是市場成長的挑戰。儘管有這些市場限制，核醫市場仍提供了巨大的成長機會，特別是在對先進醫療服務需求不斷成長的新興國家。核子醫學在阿茲海默症和帕金森氏症等神經系統疾病的診斷和治療中的應用日益廣泛，這是市場擴張的另一個有希望的機會。

本報告的主要特點

本報告對全球核子醫學市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球核子醫學市場的主要企業是根據以下參數列出的，例如公司概況、產品系列、主要亮點、財務表現和策略。
透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球核子醫學市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球核子醫學市場的各種策略矩陣更輕鬆地做出決策。

Siemens Healthineers
GE Healthcare
Philips Healthcare
Toshiba Medical Systems
Bracco Imaging
Canon Medical Systems
EczacA+-baAYA+--Monrol
Mallinckrodt Pharmaceuticals
Lantheus Medical Imaging
Bayer AG
RadioMedix
IBA Radiopharma Solutions
Nordion（a Sotera Health company）
Advanced Accelerator Applications
Actinium Pharmaceuticals

第9章分析師建議

“命運之輪”
分析師觀點
Coherent Opportunity Map (COM)

第10章參考文獻與調查方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI8016

Nuclear Medicine Market is estimated to be valued at USD 18.32 Bn in 2025 and is expected to reach USD 38.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 18.32 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.20%	2032 Value Projection:	USD 38.52 Bn

The global nuclear medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in nuclear medicine technology, and the growing demand for personalized medicine. Nuclear medicine involves the use of radioactive substances for diagnostic and therapeutic purposes, enabling the early detection and treatment of various diseases, including cancer, cardiovascular disorders, and neurological conditions. The market encompasses a wide range of products and services, such as radiopharmaceuticals, imaging equipment, and software solutions, catering to the diverse needs of healthcare professionals and patients worldwide. As the healthcare industry continues to evolve and embrace innovative technologies, the nuclear medicine market is poised for further expansion and development in the coming years.

Market Dynamic

The global nuclear medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of chronic diseases, such as cancer and cardiovascular disorders, which require advanced diagnostic and therapeutic interventions. Additionally, the growing geriatric population worldwide is expected to fuel the demand for nuclear medicine procedures, as older individuals are more susceptible to age-related diseases. Technological advancements, including the development of hybrid imaging modalities and the introduction of novel radiopharmaceuticals, are also driving market growth by improving the accuracy and efficiency of nuclear medicine procedures. However, the market faces certain restraints, such as the high cost of nuclear medicine equipment and the stringent regulatory requirements for the approval and use of radiopharmaceuticals. The shortage of skilled professionals trained in nuclear medicine techniques also poses a challenge to market growth. Despite these restraints, the nuclear medicine market presents significant opportunities for growth, particularly in emerging economies, where there is a rising demand for advanced healthcare services. The increasing adoption of nuclear medicine in the diagnosis and treatment of neurological disorders, such as Alzheimer's and Parkinson's disease, is another promising opportunity for market expansion.

Key Features of the Study

This report provides in-depth analysis of the global nuclear medicine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nuclear medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Bracco Imaging, Canon Medical Systems, EczacIbasI-Monrol, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging, Bayer AG, RadioMedix, IBA Radiopharma Solutions, Nordion (a Sotera Health company), Advanced Accelerator Applications, and Actinium Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine market

Market Segmentation

Type Insights (Revenue, USD Bn, 2020 - 2032)
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Tc-99m
- I-123
- Tl-201
- Ga-67
- Other SPECT Isotopes
- PET Radiopharmaceuticals
- F-18
- Rb-82
- Other PET Isotopes
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Ra-223
- Beta Emitters
- I-131
- Y-90
- Sm-153
- Lu-177
- Re-186
- Other Beta Emitters
- Brachytherapy Isotopes
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Bone Metastasis
- Gastroenterology
- Pulmonology
- Infectious Diseases
- Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals & Clinics
- Diagnostic Centers
- Research Laboratories
- Academic Institutions
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Toshiba Medical Systems
- Bracco Imaging
- Canon Medical Systems
- EczacIbasI-Monrol
- Mallinckrodt Pharmaceuticals
- Lantheus Medical Imaging
- Bayer AG
- RadioMedix
- IBA Radiopharma Solutions
- Nordion (a Sotera Health company)
- Advanced Accelerator Applications
- Actinium Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nuclear Medicine Market, By Type
- Global Nuclear Medicine Market, By Application
- Global Nuclear Medicine Market, By End User
- Global Nuclear Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Nuclear Medicine Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostic Nuclear Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - SPECT Radiopharmaceuticals
    - Tc-99m
    - I-123
    - Tl-201
    - Ga-67
    - Other SPECT Isotopes
  - PET Radiopharmaceuticals
    - F-18
    - Rb-82
Therapeutic Nuclear Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Alpha Emitters
    - Ra-223
  - Beta Emitters
    - I-131
    - Y-90
    - Sm-153
    - Lu-177
    - Re-186
    - Other Beta Emitters
  - Brachytherapy Isotopes
    - Cesium-131
    - Iodine-125
    - Palladium-103
    - Iridium-192
    - Others

5. Global Nuclear Medicine Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bone Metastasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pulmonology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Nuclear Medicine Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Nuclear Medicine Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toshiba Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
EczacA+-baAYA+--Monrol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantheus Medical Imaging
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RadioMedix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
IBA Radiopharma Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nordion (a Sotera Health company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Accelerator Applications
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actinium Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies